Oxford BioMedica (OXBDF) Q4 2022 Earnings Report
OXBDF Q4 2022 EPS Results
- Actual EPS
- -$0.19
- Consensus EPS
- -$0.09
- Beat/Miss
- Missed by -$0.10
- One Year Ago EPS
- $0.01
OXBDF Q4 2022 Revenue Results
- Actual Revenue
- $100.60M
- Expected Revenue
- $87.14M
- Beat/Miss
- Beat by +$13.46M
- YoY Revenue Growth
- +23.43%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 04/25/2023
- Time
- Before Open
- Conference Call
- Tuesday, April 25, 2023
OXBDF Upcoming Earnings
Oxford BioMedica's next earnings date is estimated for April 15, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
OXBDF Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
OXBDF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 15, 2027 | 2026 (Q4) | -0.03- | -0.07 | ― | ― |
| Sep 22, 2026 | 2026 (Q2) | -0.38-0.40 | -0.34 | -19.69% (-0.07) | |
| Mar 26, 2026 | 2025 (Q4) | -0.10-0.07 | -0.1 | 29.87% (+0.03) | |
| Sep 23, 2025 | 2025 (Q2) | -0.32-0.34 | -0.41 | 17.80% (+0.07) | |
| Apr 09, 2025 | 2024 (Q4) | -0.10-0.10 | -1.5 | 93.21% (+1.40) | |
| Sep 23, 2024 | 2024 (Q2) | -0.37-0.41 | -0.66 | 37.83% (+0.25) | |
| Apr 29, 2024 | 2023 (Q4) | -0.65-1.50 | -0.19 | -682.07% (-1.31) | |
| Sep 20, 2023 | 2023 (Q2) | -0.47-0.66 | -0.36 | -82.05% (-0.30) | |
| Apr 25, 2023 | 2022 (Q4) | -0.09-0.19 | 0.01 | -1418.18% (-0.21) | |
| Sep 15, 2022 | 2022 (Q2) | -0.10-0.36 | 0.28 | -227.57% (-0.64) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed